Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Milestone Pharmaceuticals Inc
MISTCurrent price
1.81 USD
-0.06 USD (-3.21%)
Last closed
1.87 USD
Company
www.milestonepharma.com
ISIN
CA59935V1076
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
105 473 808 USD
Yield for 12 month
-20.26 %
1Y
3Y
5Y
10Y
15Y
MIST
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers. The company was incorporated in 2003 and is headquartered in Montréal, Canada. Address: 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.25 USDP/E ratio
–Dividend Yield
–Current Year
+1 000 000 USD
Last Year
+5 000 000 USD
Current Quarter
–
Last Quarter
-868 002 USD
Current Year
+402 000 USD
Last Year
+5 000 000 USD
Current Quarter
-26 000 USD
Last Quarter
-28 000 USD
Key Figures MIST
1 year
3 years
5 years
10 years
EBITDA
-49 194 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-33.09 %
PEG Ratio
–
Return On Equity TTM
-133.75 %
Wall Street Target Price
10.25 USD
Revenue TTM
–
Book Value
0.48 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
5 000 000 USD
Earnings per share
-1.01 USD
Diluted Eps TTM
-1.01 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MIST
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MIST
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MIST
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
81.4416
Price Sales TTM
91.9492
Enterprise Value EBITDA
-1.4278
Price Book MRQ
3.2983
Financials MIST
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MIST
For 52 weeks
1.12 USD
3.52 USD
50 Day MA
1.51 USD
Shares Short Prior Month
436 935
200 Day MA
1.55 USD
Short Ratio
4.79
Shares Short
449 574
Short Percent
0.85 %
BeatStart